Invention Grant
![Imidazo[1,2-a]pyridine compounds](/docs/US/2013-07-30/US08497278B2/abs.jpg.600x600.jpg)
- Patent Title: Imidazo[1,2-a]pyridine compounds
- Patent Title (中): 咪唑并[1,2-a]吡啶化合物
-
Application No.: US12993679Application Date: 2009-05-19
-
Publication No.: US08497278B2Publication Date: 2013-07-30
- Inventor: Qun Kevin Fang , Frank Xinhe Wu , Paul T. Grover , Seth C. Hopkins , Una Campbell , Milan Chytil , Kerry L. Spear
- Applicant: Qun Kevin Fang , Frank Xinhe Wu , Paul T. Grover , Seth C. Hopkins , Una Campbell , Milan Chytil , Kerry L. Spear
- Applicant Address: US MA Marlborough
- Assignee: Sunovion Pharmaceuticals Inc.
- Current Assignee: Sunovion Pharmaceuticals Inc.
- Current Assignee Address: US MA Marlborough
- Agency: Heslin Rothenberg Farley & Mesiti P.C.
- International Application: PCT/US2009/044525 WO 20090519
- International Announcement: WO2009/143156 WO 20091126
- Main IPC: C07D249/08
- IPC: C07D249/08 ; C07D271/06 ; C07D403/12 ; A61K31/506 ; A61K31/4245
![Imidazo[1,2-a]pyridine compounds](/abs-image/US/2013/07/30/US08497278B2/abs.jpg.150x150.jpg)
Abstract:
Imidazo[1,2-a]pyridines are disclosed. Compounds of the invention are useful therapeutic agents and their inclusion in pharmaceutical formulations and use in methods of treatment are disclosed. Many of the compounds disclosed herein may be represented by the following generic formula: in which Y is a direct bond or heteroatom and A3 is usually a nitrogenous heterocycle.
Public/Granted literature
- US20110166146A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS Public/Granted day:2011-07-07
Information query
